Selective molecular recognition, C-H bond activation, and catalysis in nanoscale reaction vessels

Supramolecular chemistry represents a way to mimic enzyme reactivity by using specially designed container molecules. We have shown that a chiral self-assembled M4L6 supramolecular tetrahedron can encapsulate a variety of cationic guests with varying degrees of stereoselectivity. Reactive iridium guests can be encapsulated, and the C-H bond activation of aldehydes occurs with the host cavity controlling the ability of substrates to interact with the metal center based upon size and shape. In addition, the host container can act as a catalyst by itself. By restricting reaction space and preorganizing the substrates into reactive conformations, it accelerates the sigmatropic rearrangement of enammonium cations.     

Temperature Measurement Deviation during Annealing of Multiphase Steels

A pyrometric analysis of the temperature of continuous annealed strip material is an essential component of industrial production. However, despite calibration, the development of composition-dependent oxides during annealing prevents an accurate pyrometric measurement of actual strip temperature. An Al-based and a Si-based transformation induced plasticity (TRIP)-assisted steel were pyrometrically analyzed during annealing under a reducing atmosphere (5 pct H₂ and 95 pct Ar). Oxide development on both steels led to a deviation between pyrometer readings and simultaneous thermocouple measurements. The developing oxides influenced the pyrometer readings to different extents because of unique emissivities and different growth kinetics.     

Dyshematopoiesis in de novo acute myeloid leukemia: cell biological features and prognostic significance

Dyshematopoiesis was found in 44 (42.3%) of 104 cases of de novo acute myeloid leukemia (AML). Dyshematopoietic AML (dys-AML) and AML without hematopoietic dysplasia (non-dys-AML) were compared with regard to biological, hematological, immunophenotypic, and cytogenetic parameters as well as prognostic criteria. Median age of patients was 55 years in both groups. In dys-AML, the median leukocyte count (p = 0.04), peripheral blast (p = 0.02) and medullary blast cell count (p < 0.001) were significantly decreased, whereas the median platelet count (p - 0.04) was increased. Immunophenotyping demonstrated that leukemic blast cells in dys-AML more frequently expressed the adhesion molcules CD54 (p = 0.05) and CD58 (p = 0.08) than leukemic cells in non-dys-AML. Cytogenetically, we distinguished two karyotypic patterns, one group with a normal karyotype or prognostically favorable single chromosome aberrations ("P(0)-karyotype"), and another one with unfavorable single aberrations or complex aberrations ("P(1)-karyotype"). The incidence of these groups was not significantly different between dys-AML and non-dys-AML. Complete remission rate (CRR) after induction chemotherapy (p = 0.03) and overall survival time (OS; p = 0.03) were significantly lower in dys-AML. In addition, median disease free survival (DFS; p = n.s.) was inferior compared to non-dys-AML. In the dys-AML as well as in the non-dys-AML patient group, CRR, DFS, and OS were decreased in the P(1)-compared to the P(0)-subgroup. We conclude that dyshematopoietic AML is characterized by specific cell biological features and that hematopoietic and cytogenetic status represent complementary prognostic factors in de novo AML.     

Automatic control of airway pressure for treatment of obstructivesleep apnea

Obstructive sleep apnea (OSA) occurs when airflow ceases because of pharyngeal wall collapse in sleep. Repeated apneic events results in the development of a pathological condition called OSA syndrome. The authors describe the methodology and design of a prosthetic device, named automatic positive airway pressure (APAP), for treatment of this syndrome. HPAP applies a stream of air via a nasal mask at an initial pressure selected by the patient. By sensing specific pressure characteristics of air flow immediately preceding pharyngeal wall collapse, the APAP device automatically raises the applied pressure to maintain a patent upper airway and thus prevent apnea. Conversely, when such conditions are absent, pressure is lowered step wise until a preselected minimum pressure is reached. Performance evaluation of the APAP system in five OSA patients and five normal (asymptomatic for sleep apnea) subjects revealed that it effectively treated OSA syndrome. It lowered the apnea-hypopnea index without disturbing sleep and resulted in a lower mean airway pressure compared to the traditional continuous positive airway pressure (CPAP) therapy. The results also show that the pressure needed to prevent OSA varied significantly throughout the night. For OSA syndrome patients, this pressure ranged from 3 to 18 cm H ₂O. The mean airway pressure for these patients had a sample average of 6.80 cm H₂O and a standard deviation of 3.17 cm H ₂O. In normal subjects, the device did not raise pressure except in response to pharyngeal wall vibration events     

A noninvasive technique for detecting obstructive and central sleepapnea

A new noninvasive method to detect obstructive and central sleep apnea [(OSA) and (CSA)] events is described. Data were collected from ten volunteer subjects with a previous diagnosis of OSA while they were titrated for continuous positive airway pressure (CPAP) therapy. Apneic events were identify by analyzing of estimated airway impedance determined from pressure and airflow signals delivered from CPAP. To enhance performance of this technique, a single-frequency (5 Hz with 0.5 cmH₂O peak-to-peak amplitude) probing signal was superimposed on the applied CPAP pressure. The results indicated that estimated airway impedance during OSA (mean: 17.9, SD: 3.4, N=50) was significantly higher then during CSA (mean: 4.1, SD: 1.7, N=50). When the estimated impedance of OSA and CSA events were compared to a fixed threshold, 100% of all events can be correctly categorized. These results indicate that it may be possible to diagnose OSA and CSA noninvasively based upon this technique. The instrument and the algorithm required are relatively simple and can be incorporated in a home-based device. If this method was used for prescreening apnea patients, it could reduce cost, waiting time, and discomfort associated with traditional diagnostic procedures     

1200 V 4H-SiC Bipolar Junction Transistors with A Record β of 70

A common current gain of 70 has been achieved in 4H-SiC bipolar junction transistors (BJTs) at room temperature, which is the highest among those reported. BJTs having an active area of 4 mm × 4 mm exhibit a specific on-resistance of 6.3 mΩ cm² at 25°C, which increases to 17.4 mΩ cm² at 250°C. BV_CEO (the breakdown voltage from collector to emitter with open base) and BV_CBO (the breakdown voltage from collector to base with open emitter) of 1200 V were observed at <5 μA leakage currents at all temperatures up to 250°C. Dynamic characteristics were measured using the IXYS RF/Directed Energy IXDD415 gate driver evaluation board to drive the BJT. A collector current (I _C) rise time at turn-on of 32 ns was measured with a 1.6 A gate current provided to support the collector current of 63 A. An I _C fall time at turn-off of 16 ns was achieved.